Company Forma Therapeutics Holdings, Inc.
Equities
FMTX
US34633R1041
Biotechnology & Medical Research
Business Summary
Number of employees: 189
Managers
Managers | Title | Age | Since |
---|---|---|---|
Todd Shegog
DFI | Director of Finance/CFO | 59 | 31/08/19 |
President | - | 13/10/22 | |
David N. Cook
CTO | Chief Tech/Sci/R&D Officer | 66 | 31/03/20 |
Mario Corso
IRC | Investor Relations Contact | - | 31/08/20 |
Ifeyinwa Osunkwo
PRN | Corporate Officer/Principal | - | 31/12/21 |
Ruth du Moulin
PRN | Corporate Officer/Principal | - | 15/09/20 |
Jeannette Potts
LAW | General Counsel | 62 | 31/08/19 |
Mary Wadlinger
HRO | Human Resources Officer | 64 | 10/09/14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Haagen
BRD | Director/Board Member | 58 | 13/10/22 |
President | - | 13/10/22 | |
Steve Benz
BRD | Director/Board Member | - | 13/10/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 47,856,812 | 45,795,107 ( 95.69 %) | 4,255 ( 0.008891 %) | 95.69 % |
Company contact information
Forma Therapeutics Holdings, Inc.
300 North Beacon Street Suite 501
02472, Watertown
+
Sector
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |